208 related articles for article (PubMed ID: 20195667)
1. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
4. Insight into the enzyme-inhibitor interactions of the first experimentally determined human aromatase.
Punetha A; Shanmugam K; Sundar D
J Biomol Struct Dyn; 2011 Apr; 28(5):759-71. PubMed ID: 21294587
[TBL] [Abstract][Full Text] [Related]
5. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
[TBL] [Abstract][Full Text] [Related]
6. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools.
Mitra I; Saha A; Roy K
J Mol Model; 2012 Aug; 18(8):3951-67. PubMed ID: 22434311
[TBL] [Abstract][Full Text] [Related]
7. Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
Singh Y; Jaswal S; Singh S; Verma SK; Thareja S
J Biomol Struct Dyn; 2023 Dec; 41(20):10604-10626. PubMed ID: 36510679
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors.
Banjare L; Singh Y; Verma SK; Singh AK; Kumar P; Kumar S; Jain AK; Thareja S
J Biomol Struct Dyn; 2023 Mar; 41(4):1322-1341. PubMed ID: 34963408
[TBL] [Abstract][Full Text] [Related]
10. Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.
Roy K; Pratim Roy P
Eur J Med Chem; 2009 Jul; 44(7):2913-22. PubMed ID: 19128860
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors.
Pingaew R; Mandi P; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2018 Jan; 143():1604-1615. PubMed ID: 29137864
[TBL] [Abstract][Full Text] [Related]
12. Docking and 3D QSAR studies of protoporphyrinogen oxidase inhibitor 3H-pyrazolo[3,4-d][1,2,3]triazin-4-one derivatives.
Roy K; Paul S
J Mol Model; 2010 Jan; 16(1):137-53. PubMed ID: 19543755
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
Leechaisit R; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2019 Oct; 27(19):115040. PubMed ID: 31416738
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling evaluation of non-steroidal aromatase inhibitors.
Narayana BL; Pran Kishore D; Balakumar C; Rao KV; Kaur R; Rao AR; Murthy JN; Ravikumar M
Chem Biol Drug Des; 2012 May; 79(5):674-82. PubMed ID: 22129073
[TBL] [Abstract][Full Text] [Related]
15. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
16. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
17. Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity.
Barigye SJ; Freitas MP; Ausina P; Zancan P; Sola-Penna M; Castillo-Garit JA
ACS Comb Sci; 2018 Feb; 20(2):75-81. PubMed ID: 29297675
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
19. Docking and 3D-QSAR studies of acetohydroxy acid synthase inhibitor sulfonylurea derivatives.
Roy K; Paul S
J Mol Model; 2010 May; 16(5):951-64. PubMed ID: 19841951
[TBL] [Abstract][Full Text] [Related]
20. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Nagar S; Saha A
Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]